• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Viavi Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    5/1/25 4:18:11 PM ET
    $VIAV
    Semiconductors
    Technology
    Get the next $VIAV alert in real time by email
    viav-20250501
    0000912093false00009120932025-05-012025-05-01


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): May 1, 2025
    VIAVI SOLUTIONS INC.
    (Exact name of Registrant as specified in its charter)
     
    Delaware 000-22874 94-2579683
    (State or other jurisdiction
    of incorporation or organization)
     (Commission file number) (I.R.S. Employer
    Identification Number)
    1445 South Spectrum Blvd, Suite 102Chandler,Arizona85286
    (Address of principal executive offices and Zip Code)
     (408) 404-3600
    (Registrant’s telephone number, including area code) 
     
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of the exchange on which registered
    Common Stock, par value of $0.001 per shareVIAVThe Nasdaq Stock Market LLC

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b) 
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
    Emerging growth company. ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 2.02. Results of Operations and Financial Condition.
    On May 1, 2025, Viavi Solutions Inc. (the “Company”) reported its preliminary results for its fiscal third quarter ended March 29, 2025. A copy of the Company’s press release is furnished herewith and attached hereto as Exhibit 99.1. 
    The information in Item 2.02 and Exhibit 99.1 of this Current Report on Form 8-K is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

    Item 9.01. Financial Statements and Exhibits.
     
    (d)   Exhibits.
     
    Exhibit No. Description
    99.1
     Press release entitled “VIAVI Announces Third Quarter Fiscal 2025 Results” dated May 1, 2025.
    104Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document



    Signature
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     VIAVI SOLUTIONS INC.
     By:/s/ ILAN DASKAL
     Name:ILAN DASKAL
     Title:Executive Vice President and Chief Financial Officer
     (Duly Authorized Officer and Principal Financial and Accounting Officer)
      
    May 1, 2025
     


    Get the next $VIAV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VIAV

    DatePrice TargetRatingAnalyst
    3/7/2025$14.00Neutral → Buy
    Rosenblatt
    1/31/2025$15.00Hold → Buy
    Needham
    12/17/2024$8.00 → $9.50Equal-Weight → Underweight
    Morgan Stanley
    11/19/2024$10.60Neutral
    UBS
    6/26/2024$8.25Buy → Neutral
    Rosenblatt
    5/3/2024$9.00Positive → Neutral
    Susquehanna
    2/12/2024$10.00 → $13.00Hold → Buy
    Stifel
    12/2/2022$12.00Hold
    Stifel
    More analyst ratings